
.webp&w=3840&q=75)
Syneos Health, Farnborough UK
29 April 2025

The Spine Building, Liverpool UK
9 November 2023

Beaumont Estate, Windsor UK
29 June 2022
29 April 2025
29 June 2022
"The training is extremely user friendly, easy to use and makes learning ICH-GCP so much more accessible and dare I say it…enjoyable."
CRunch Learner
Global CRO
"The training course was easy and clear to understand, and also easy to manage completing it with the daily presentations and tasks"
CRunch Learner
Global CRO
"Short sharp bursts of learning work well, plus the daily reminders were very useful"
CRunch Learner
Global CRO
"An easy way to follow and learn, which also gives you time to do it alongside your regular work. You don't have to sit for hours to complete it and it's great that you don't have to complete everything in the same day."
CRunch Learner
Clinical Research Site
"The daily tasks are very useful to help remember the concepts"
CRunch Learner
Clinical Research Site
"Having worked in clinical research for several years I decided to complete the IAOCR investigator accreditation to ensure that I could demonstrate formal recognition of an internationally accepted program that proves my competence and ability to work to best practice global standards. I found the online examination straight forward and the staff at IAOCR to be very responsive to my enquiries. Having now gained accreditation, I believe that Sponsors, CROS and other stakeholders within the clinical research space will have utmost confidence that they are collaborating with a globally recognised Clinical Research Investigator."
Dr Nischal Sahai
Clinical Research UniSC, Clinical Trials – Brisbane
Principal Medical Investigator
"Qualifying staff to work in clinical trials based on number of years’ experience provides false reassurance of quality and also fuels the industry’s talent crisis. When an individual gains IAOCR accreditation I know they have been robustly competence checked… …The IAOCR approach reduces risk to clinical research and provides a reliable and trusted pathway for new talent."
Sam Kerr
Merz Aesthetics
Chief Scientific Officer
"At Re:Cognition Health, we are always working on ways to improve quality and efficiency in our clinical trials, which means having a fantastic team. We implemented the IAOCR individual accreditations this year, as a way of externally assessing our staff team’s understanding and application of ICH GCP to their roles and duties, as well as assessing their wider understanding of clinical trials. This process has helped us recognize, company-wide our wonderful staff and supported their professional development. More importantly, it has helped us identify training gaps, so we can consider additional training need."
Vicky Eyre
Re:Cognition Health
UK Director of Clinical Trials
"Our BPQC certification journey began on Clinical Trials Day, this year, which was no coincidence. At Momentum Pharma we absolutely live and breathe the values promoted on Clinical Trials Day: the pursuit of knowledge, best practice, and unwavering commitment to patient well-being. Through these values, clinical investigators, research sites and clinical trial staff work tirelessly to research new medicine and bring hope to millions of patients and their families. This became our launch pad to drive us forward in the pursuit of our goal to achieve the highest recognition possible, IAOCR Business Process Quality Certification. We are thrilled to announce that all three areas reviewed, Governance, Business Strategy and Workforce Process Quality, have fully met the rigorous assessment criteria.” Melissa Melton, CEO and Co-Founder."
Melissa Melton
Momentum Pharma CRO
CEO and Co-Founder
"As a board member for the GCSA Global Advisory Board, it is possible to see the difference that this certification for the global quality standard for sites will make to the ongoing delivery of clinical trials in our ever-challenging environment. The benefits of the certification include transparency for both sites and sponsors, enabling reassurance and trust in the commitment to the delivery of the highest quality research and facilitation of true synergistic partnerships across the clinical trial landscape."
Fiona Shields
Study and Site Operations Country Head (Global Sponsor)
"The GCSA certification process offered more than just validation – it was a true opportunity for reflection and growth. It enabled us to celebrate areas of strength whilst also identifying opportunities to further refine and enhance our processes. The Certification reinforces the credibility and quality of our research operations through independent external review. Ultimately, it supports our continued commitment to delivering high-quality experiences for both patients and sponsors."
Sophie Mepham
ICON Group
Executive Manager for Research
"At AGA Clinical Trials, we are dedicated to demonstrating how we are a global center of excellence and the GCSA and IAOCR certifications were the logical next steps for us to achieve our mission of improving health and quality of life for our patients. The GCSA and subsequent IAOCR certification processes were in-depth and detailed, which allowed our team to reflect on our working processes beyond the core assessment. We’re delighted with the results because we are truly committed to working to the highest Industry standards."
Dr. Maria Graber
AGA Clinical Trials
CEO
"We take what we do very seriously, because of the impact our trials can have on our patients and their families. We wanted to ensure we were providing the best quality service to our patients, their families, the Sponsors and CRO clients, whilst also developing our team. Through the independent GCSA assessment, we have been able to demonstrate and embed best practices and processes."
Vicky Eyre
Re: Cognition Health (UK)
Director of UK Clinical Trials
"As a board member for the GCSA Global Advisory Board, it is possible to see the difference that this certification for the global quality standard for sites will make to the ongoing delivery of clinical trials in our ever-challenging environment. The benefits of the certification include transparency for both sites and sponsors, enabling reassurance and trust in the commitment to the delivery of the highest quality research and facilitation of true synergistic partnerships across the clinical trial landscape."
Fiona Shields
Global Sponsor
Study and Site Operations Country Head
"As a sponsor of dermatology trials, the GCSA certification standard gives me confidence that sites are working to a global quality standard and have been independently audited by IAOCR. When a site is GCSA Certified I have confidence that they will be a high-quality partner for our clinical trials."
Dr Sam Kerr
Global Sponsor
Chief Scientific Officer
"Workforce Quality Accreditation is one of the most rewarding programs I have ever worked on. It is not a check box exercise, it’s part of a continual improvement process—we learned a lot about ourselves: what we do well, what we can improve upon and how to fill gaps. IAOCR will not waiver from their standards—gaining the Clinical Operations Workforce Quality Accreditation really means something!"
Richard Wood
Syneos Health
Senior Director, Global Operations
"This Gold award allows us to market for commercial research, as it’s an indicator of our quality. It provides a layer of assurance for the Trust in terms of an external assessment and where we’re at in terms of our clinical research workforce"
Heather Rice
RDaSH
Director of Research & Innovation
"I would absolutely recommend IAOCR. They’ve really helped us over the last couple of years, re-organize the way we deliver training. I think the way they go about their business is very diligent, it’s quite strict, which I think you need when you’re setting up levels of competence for the industry. IAOCR have really helped us shape out thoughts around competence over the last four or five years."
Alistair MacDonald
Syneos Health
CEO
"I would absolutely recommend IAOCR. In all my dealings with them I’ve found them to be highly professional, extremely focused, and I’ve been delighted to be a member of the Executive Advisory Board and part of the Workforce Quality Accreditation program. I think [IAOCR accreditation] has the real potential to be adopted across the industry. The fact that there is an accreditation process where none existed before, we are looking at common competencies that work across academia, across CRO and pharma. This is something to be absolutely celebrated!"
Graham Belgrave
Cmed Clinical Services
Chief Operating Officer
"I think they’re really shaping the industry, they were the primary and first people speaking about competency….IAOCR are the frontier of how we should be evaluating clinical research professionals. It’s the wave of the future and I'd like to see the industry embrace it as a whole."
Elizabeth Edwards
(Formerly Biomat)
Independent Consultant
"The Project Management Course provided by IAOCR was a new and innovative way of providing this kind of training within this industry. My team contained people with varying experience and they all benefitted from it, even though some of them did not meet the accreditation criteria. The follow up work by IAOCR was excellent and really got my team thinking about the training and using it in real life examples which is rarely achieved with other training methods. The main selling point is the fact that participants have to demonstrate understanding, and that really opened my eyes to the ability of my staff within my team."
Lucy Thompson
RDCM Clinical Services Europe
Associate Director